BIO Asia–Taiwan 2025 亞洲生技大會

From Taiwan to the World: Bridging Innovation and Global Collaboration

Join us for an inspiring deep dive into the cutting-edge advancements shaping the future of precision health. Session A10 brings together global leaders in biotech, genomics, and AI to share their insights, experiences, and visions for transforming healthcare in Taiwan and beyond.

Opening remarks will be delivered by representatives from the Ministry of Economic Affairs (MOEA), the American Institute in Taiwan (AIT), and ITRI.

This session features thought-provoking talks by leading voices from AstraZeneca, Illumina, ITRI, and Big4Bio, who will share how AI, big data, whole genome sequencing (WGS), and multi-omics biobank partnerships are accelerating breakthroughs in drug discovery and transforming the future of precision medicine.

The session concludes with a dynamic panel discussion titled "From Global Vision to Local Possibilities: Exploring the Future of WGS in Taiwan," moderated by Eric Y. Chuang of ITRI, with panelists from AstraZeneca, Illumina, National Health Research Institutes(NHRI), and Big4Bio.

Don't miss this opportunity to gain global perspectives and local insights into how Taiwan can lead the next wave of biotech innovation.

Register Now & Save $100
Deadline: July 15